153
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Molecular docking and molecular dynamics simulation analysis of bioactive compounds of Cichorium intybus L. seed against hepatocellular carcinoma

, & ORCID Icon
Received 05 Dec 2022, Accepted 12 Aug 2023, Published online: 25 Aug 2023

References

  • Ahmed, B., Khan, S., Masood, M. H., & Siddique, A. H. (2008). Anti-hepatotoxic activity of cichotyboside, a sesquiterpene glycoside from the seeds of Cichorium intybus. Journal of Asian Natural Products Research, 10(3–4), 223–231. https://doi.org/10.1080/10286020701590764
  • Al-Snafi, A. E. (2016). Medical importance of Cichorium intybus: A review. IOSR Journal of Pharmacy, 6(3), 41–56.
  • Apostolou, A., Stagos, D., Galitsiou, E., Spyrou, A., Haroutounian, S., Portesis, N., Trizoglou, I., Wallace Hayes, A., Tsatsakis, A. M., & Kouretas, D. (2013). Assessment of polyphenolic content, antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of Vitis vinifera stem extracts. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 61, 60–68. https://doi.org/10.1016/j.fct.2013.01.029
  • Ashour, A. E., Abd-Allah, A. R., Korashy, H. M., Attia, S. M., Alzahrani, A. Z., Saquib, Q., Bakheet, S. A., Abdel-Hamied, H. E., Jamal, S., & Rishi, A. K. (2014). Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Molecular and Cellular Biochemistry, 389(1–2), 85–98. https://doi.org/10.1007/s11010-013-1930-1
  • Banerjee, P., Eckert, O. A., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/nar/gky318
  • Brito, A. F., Abrantes, A. M., Pinto-Costa, C., Gomes, A. R., Mamede, A. C., Casalta-Lopes, J., Gonçalves, A. C., Sarmento-Ribeiro, A. B., Tralhão, J. G., & Botelho, M. F. (2012). Hepatocellular carcinoma and chemotherapy: The role of p53. Chemotherapy, 58(5), 381–386. https://doi.org/10.1159/000343656
  • Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/10.1063/1.2408420
  • Chaudhary, N., & Aparoy, P. (2017). Deciphering the mechanism behind the varied binding activities of COXIBs through molecular dynamic simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies. Journal of Biomolecular Structure & Dynamics, 35(4), 868–882. https://doi.org/10.1080/07391102.2016.1165736
  • Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/ci300367a
  • Chuang, S. C., La Vecchia, C., & Boffetta, P. (2009). Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Letters, 286(1), 9–14. https://doi.org/10.1016/j.canlet.2008.10.040
  • Daneman, R., & Prat, A. (2015). The blood-brain barrier. Cold Spring Harbor perspectives in biology, 7(1), a020412. https://doi.org/10.1101/cshperspect.a020412
  • Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
  • Desai, A. G., Qazi, G. N., Ganju, R. K., El-Tamer, M., Singh, J., Saxena, A. K., Bedi, Y. S., Taneja, S. C., & Bhat, H. K. (2008). Medicinal plants and cancer chemoprevention. Current Drug Metabolism, 9(7), 581–591. https://doi.org/10.2174/138920008785821657
  • Elmeliegy, M., Vourvahis, M., Guo, C., & Wang, D. D. (2020). Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: Review of clinical drug–drug interaction studies. Clinical Pharmacokinetics, 59(6), 699–714. https://doi.org/10.1007/s40262-020-00867-1
  • Elzouki, A. N., & Eriksson, S. (1996). Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): Is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? European Journal of Gastroenterology & Hepatology, 8(10), 989–994. https://doi.org/10.1097/00042737-199610000-00010
  • Fracanzani, A. L., Conte, D., Fraquelli, M., Taioli, E., Mattioli, M., Losco, A., & Fargion, S. (2001). Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease. Hepatology (Baltimore, Md.), 33(3), 647–651. https://doi.org/10.1053/jhep.2001.22506
  • Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
  • Grienke, U., Braun, H., Seidel, N., Kirchmair, J., Richter, M., Krumbholz, A., von Grafenstein, S., Liedl, K. R., Schmidtke, M., & Rollinger, J. M. (2014). Computer-guided approach to access the anti-influenza activity of licorice constituents. Journal of Natural Products, 77(3), 563–570. https://doi.org/10.1021/np400817j
  • Grienke, U., Mihály-Bison, J., Schuster, D., Afonyushkin, T., Binder, M., Guan, S-h., Cheng, C-r., Wolber, G., Stuppner, H., Guo, D-a., Bochkov, V. N., & Rollinger, J. M. (2011). Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum. Bioorganic & Medicinal Chemistry, 19(22), 6779–6791. https://doi.org/10.1016/j.bmc.2011.09.039
  • He, X., & Liu, R. H. (2006). Cranberry phytochemicals: Isolation, structure elucidation, and their antiproliferative and antioxidant activities. Journal of Agricultural and Food Chemistry, 54(19), 7069–7074. https://doi.org/10.1021/jf061058l
  • Heinze, T., Jonas, S., Kärsten, A., & Neuhaus, P. (1999). Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. Anticancer Research, 19(4A), 2501–2503.
  • Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
  • Hess, B., Kutzner, C., Van Der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3), 435–447. https://doi.org/10.1021/ct700301q
  • Ikram, N. K. K., Durrant, J. D., Muchtaridi, M., Zalaludin, A. S., Purwitasari, N., Mohamed, N., Rahim, A. S. A., Lam, C. K., Normi, Y. M., Rahman, N. A., Amaro, R. E., & Wahab, H. A. (2015). A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity. Journal of Chemical Information and Modeling, 55(2), 308–316. https://doi.org/10.1021/ci500405g
  • Janda, K., Gutowska, I., Geszke-Moritz, M., & Jakubczyk, K. (2021). The common cichory (Cichorium intybus L.) as a source of extracts with health-promoting properties—a review. Molecules (Basel, Switzerland), 26(6), 1814. https://doi.org/10.3390/molecules26061814
  • Khan, T., Ali, M., Khan, A., Nisar, P., Jan, S. A., Afridi, S., & Shinwari, Z. K. (2019). Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules, 10(1), 47. https://doi.org/10.3390/biom10010047
  • Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa― A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
  • Kuruppu, A. I., Paranagama, P., & Goonasekara, C. L. (2019). Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka. Saudi Pharmaceutical Journal : SPJ : The Official Publication of the Saudi Pharmaceutical Society, 27(4), 565–573. https://doi.org/10.1016/j.jsps.2019.02.004
  • Lee, M. S., & Olson, M. A. (2013). Comparison of volume and surface area nonpolar solvation free energy terms for implicit solvent simulations. The Journal of Chemical physics139(4), 044119_1. https://doi.org/10.1063/1.4816641
  • Lin, G. Y., Chen, Z. L., Lu, C. M., Li, Y., Ping, X. J., & Huang, R. (2000). Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World Journal of Gastroenterology, 6(2), 234.
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
  • Liu, Y. Z., Wang, X. L., Wang, X. Y., Yu, R. L., Liu, D. Q., & Kang, C. M. (2016). De novo design of VEGFR-2 tyrosine kinase inhibitors based on a linked-fragment approach. Journal of Molecular Modeling, 22(9), 222. https://doi.org/10.1007/s00894-016-3088-8
  • Magnussen, A., & Parsi, M. A. (2013). Aflatoxins, hepatocellular carcinoma and public health. World Journal of Gastroenterology, 19(10), 1508–1512. https://doi.org/10.3748/wjg.v19.i10.1508
  • Malik, B., Pirzadah, T. B., Tahir, I., Abdin, M. Z., & Rehman, U. I. R. (2016). Phytochemical studies on Cichorium intybus L. (CHICORY) from Kashmir Himalaya using GC-MS. Journal of Pharmacy Research, 10(11), 715–726.
  • Moharana, M., Pattanayak, S. K., & Khan, F. (2022). Bioactive compounds from Pandanous fascicularis as potential therapeutic candidate to tackle hepatitis a inhibition: Docking and molecular dynamics simulation study. Journal of Biomolecular Structure & Dynamics, 1–17. https://doi.org/10.1080/07391102.2022.2158940
  • Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
  • Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). DS Goodsell i AJ Olson. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
  • Mushtaq, A. A., Ahmad, M. A., & Jabeen, Q. A. (2013). Pharmacological role of Cichorium intybus as a hepatoprotective agent on the elevated serum marker enzymes level in albino rats intoxicated with nimesulide. International Journal of Current Pharmaceutical Research, 5(3), 25–30.
  • Nandagopal, S., & Kumari, B. R. (2007). Phytochemical and antibacterial studies of Chicory (Cichorium intybus L.): A multipurpose medicinal plant. Advances in Biological Research, 1(1–2), 17–21.
  • Nibret, E., Youns, M., Krauth‐Siegel, R. L., & Wink, M. (2011). Biological activities of xanthatin from Xanthium strumarium leaves. Phytotherapy Research : PTR, 25(12), 1883–1890. https://doi.org/10.1002/ptr.3651
  • Olğaç, A., Orhan, I. E., & Banoglu, E. (2017). The potential role of in silico approaches to identify novel bioactive molecules from natural resources. Future Medicinal Chemistry, 9(14), 1665–1686. https://doi.org/10.4155/fmc-2017-0124
  • Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
  • Qin, J. J., Li, X., Hunt, C., Wang, W., Wang, H., & Zhang, R. (2018). Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine. Genes & Diseases, 5(3), 204–219. https://doi.org/10.1016/j.gendis.2018.07.002
  • Qin, L. X., & Tang, Z. Y. (2002). The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology, 8(3), 385–392. https://doi.org/10.3748/wjg.v8.i3.385
  • Qin, L.-X., Tang, Z.-Y., Ma, Z.-C., Wu, Z.-Q., Zhou, X.-D., Ye, Q.-H., Ji, Y., Huang, L.-W., Jia, H.-L., Sun, H.-C., & Wang, L. (2002). P53 immunohistochemical scoring: An independent prognostic marker for patients after hepatocellular carcinoma resection. World Journal of Gastroenterology, 8(3), 459–463. https://doi.org/10.3748/wjg.v8.i3.459
  • Rodrigues, T. (2017). Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point. Organic & Biomolecular Chemistry, 15(44), 9275–9282. https://doi.org/10.1039/c7ob02193c
  • Rollinger, J. M., Kratschmar, D. V., Schuster, D., Pfisterer, P. H., Gumy, C., Aubry, E. M., Brandstötter, S., Stuppner, H., Wolber, G., & Odermatt, A. (2010). 11β-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches. Bioorganic & Medicinal Chemistry, 18(4), 1507–1515. https://doi.org/10.1016/j.bmc.2010.01.010
  • Roxburgh, P., & Evans, T. R. (2008). Systemic therapy of hepatocellular carcinoma: Are we making progress? Advances in Therapy, 25(11), 1089–1104. https://doi.org/10.1007/s12325-008-0113-z
  • Saffroy, R., Lelong, J. C., Azoulay, D., Salvucci, M., Reynes, M., Bismuth, H., Debuire, B., & Lemoine, A. (1999). Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. British Journal of Cancer, 79(3–4), 604–610. https://doi.org/10.1038/sj.bjc.6690095
  • Satmbekova, D., Srivedavyasasri, R., Orazbekov, Y., Omarova, R., Datkhayev, U., & Ross, S. A. (2018). Chemical and biological studies on Cichorium intybus L. Natural Product Research, 32(11), 1343–1347. https://doi.org/10.1080/14786419.2017.1343319
  • Shad, M. A., Nawaz, H., Rehman, T., & Ikram, N. (2013). Determination of some biochemicals, phytochemicals and antioxidant properties of different parts of Cichorium intybus L.: A comparative study. Journal of Animal and Plant Sciences, 23(4), 1060–1066.
  • Shiota, G., Kishimoto, Y., Suyama, A., Okubo, M., Katayama, S., Harada, K., Ishida, M., Hori, K., Suou, T., & Kawasaki, H. (1997). Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. Journal of Hepatology, 27(4), 661–668. https://doi.org/10.1016/s0168-8278(97)80083-9
  • Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/10.3322/caac.21551
  • Sritharan, S., & Sivalingam, N. (2021). A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278, 119527. https://doi.org/10.1016/j.lfs.2021.119527
  • Strohmeyer, G., Niederau, C., & Stremmel, W. (1988). Survival and causes of death in hemochromatosis. Observations in 163 patients. Annals of the New York Academy of Sciences, 526(1), 245–257. https://doi.org/10.1111/j.1749-6632.1988.tb55510.x
  • Sugo, H., Takamori, S., Kojima, K., Beppu, T., & Futagawa, S. (1999). The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas. Surgery Today, 29(9), 849–855. https://doi.org/10.1007/BF02482774
  • Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
  • Tangkijvanich, P., Janchai, A., Charuruks, N., Kullavanijaya, P., Theamboonlers, A., Hirsch, P., & Poovorawan, Y. (2000). Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma. Asian Pacific Journal of Allergy and Immunology, 18(4), 237.
  • Tsai, W. C., Kung, P. T., Wang, Y. H., Kuo, W. Y., & Li, Y. H. (2018). Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer. PloS One, 13(6), e0199532. https://doi.org/10.1371/journal.pone.0199532
  • Wang, Y., Rosengarth, A., & Luecke, H. (2007). Structure of the human p53 core domain in the absence of DNA. Acta Crystallographica Section D, Biological Crystallography, 63(Pt 3), 276–281. https://doi.org/10.1107/S0907444906048499
  • Zareen, S., Choudhary, M. I., Akhtar, M. N., Khan, S. N. (2008). α-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus. Journal of Natural Products., 71(5):910–913.
  • Zhou, J., Fang, L., Liao, J., Li, L., Yao, W., Xiong, Z., & Zhou, X. (2017). Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo. PloS One, 12(3), e0172838. https://doi.org/10.1371/journal.pone.0172838
  • Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011). SwissParam: A fast force field generation tool for small organic molecules. Journal of Computational Chemistry, 32(11), 2359–2368. https://doi.org/10.1002/jcc.21816

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.